The collagen your body builds after Sculptra treatment becomes part of your own tissue its yours to keep. Addressing "Ozempic Face" and GLP-1 Weight Loss Facial Hollowing The widespread adoption of GLP-1 receptor agonist medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) has created one of the most rapidly growing patient concerns in cosmetic dermatology: medication-driven facial volume loss , colloquially known as Ozempic Face. While these medications are remarkably effective for weight management and metabolic health, the rapid fat loss they produce does not discriminate facial fat pads that provide youthful structure to the temples, cheeks, and jawline are depleted alongside body fat, often leaving patients with a hollow, aged appearance that contradicts the healthier physique theyve worked to achieve
Il tema si inserisce nella nuova fase delle terapie orali per lobesit, gi discussa nellarticolo sulla pillola contro lobesit: semaglutide orale e orforglipron
You should also ask about their qualifications, experience, and any potential risks or side effects associated with the procedure
They are not a replacement for healthy habits but can help make those changes more effective
Some patients notice skin laxity, dullness or reduced firmness
The price you pay reflects your knowledge of peptide therapy economics , manufacturing realities, and regulatory positioning
